Ali Al-Hakim
Advertisement
Ali Al-Hakim is acting director of Division of New Drug API at the FDA.
Articles by Ali Al-Hakim
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
2
Transforming Clinical Bioanalysis for Manufacturing Scalability
3
Mastering Phase-Appropriate Characterization for Biologics Approval
4
Maximizing Productivity and Scalability with Perfusion Technology
5
